Friday, April 24, 2020 11:53:00 AM
What I will add to their responses:
There are two things going on here...
1) We have existing drug
2) We are making more drug
So, for point 1:
We have enough drug in hand that we can supply the Phase 2 trial in South korea
So, for point 2:
We hired a chemical company in the USA to not only make more Ifenprodil for us but also look into making it in a more streamlined fashion.
Additional point:
We are going to secure IP on a novel formulation for IV use.
The implications of this go beyond our trials. If others want to use it by IV, they will be going through us.
Invest in the science.
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM
Element79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates • ELMGF • Sep 10, 2024 11:00 AM
Nightfood Holdings Inc. Completes Major Step on Uplist Journey by Closing Strategic All-Stock Acquisition of CarryoutSupplies.com • NGTF • Sep 10, 2024 8:15 AM
Element79 Gold Corp. Announces Sale of 100% Interest in Elder Creek, North Mill Creek, and Elephant Projects to 1472886 B.C. Ltd. • ELEM • Sep 9, 2024 9:34 AM